Go Pro
NASDAQ:SGRY

Surgery Partners (SGRY) Stock Price, News & Analysis

Surgery Partners logo
$14.17 +0.19 (+1.36%)
As of 04:00 PM Eastern

About Surgery Partners Stock (NASDAQ:SGRY)

Advanced

Key Stats

Today's Range
$13.88
$14.37
50-Day Range
$13.60
$17.23
52-Week Range
$11.41
$23.44
Volume
1.63 million shs
Average Volume
2.75 million shs
Market Capitalization
$1.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.45
Consensus Rating
Moderate Buy

Company Overview

Surgery Partners, Inc. operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care. The company deploys a capital-light management services model as well as joint-venture ownership structures to develop and acquire facilities in mid-sized and underserved markets. As of the most recent disclosures, Surgery Partners maintains operations in more than 25 states, serving patients through over 200 ambulatory surgery centers and multiple inpatient surgical and rehabilitation hospitals.

Headquartered in Nashville, Tennessee, Surgery Partners emphasizes clinical governance and regulatory compliance, leveraging standardized protocols to drive quality outcomes and operational efficiency. The leadership team is led by President and Chief Executive Officer Douglas Coltharp, who brings extensive experience in healthcare strategy, capital markets and operations. Under Coltharp’s guidance, the company continues to pursue selective growth opportunities while maintaining collaborative relationships with physician partners and payors to address the evolving demands of value-based care.

AI Generated. May Contain Errors.

Surgery Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

SGRY MarketRank™: 

Surgery Partners scored higher than 93% of companies evaluated by MarketBeat, and ranked 35th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Surgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.55, and is based on no strong buy ratings, 7 buy ratings, 3 hold ratings, and 1 sell rating.

  • Upside Potential

    Surgery Partners has a consensus price target of $19.45, representing about 37.3% upside from its current price of $14.17.

  • Amount of Analyst Coverage

    Surgery Partners has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Surgery Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for Surgery Partners are expected to grow by 27.27% in the coming year, from $0.22 to $0.28 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Surgery Partners is -20.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Surgery Partners is -20.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Surgery Partners has a PEG Ratio of 4.31. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Surgery Partners has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Surgery Partners' valuation and earnings.
  • Percentage of Shares Shorted

    9.86% of the float of Surgery Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    Surgery Partners has a short interest ratio ("days to cover") of 6.03.
  • Change versus previous month

    Short interest in Surgery Partners has recently decreased by 6.53%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Surgery Partners does not currently pay a dividend.

  • Dividend Growth

    Surgery Partners does not have a long track record of dividend growth.

  • News Sentiment

    Surgery Partners has a news sentiment score of 1.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Surgery Partners this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    1 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $143,500.00 in company stock, which represents 0.0077% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Surgery Partners insiders have bought more of their company's stock than they have sold. Specifically, they have bought $143,500.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    2.00% of the stock of Surgery Partners is held by insiders.

  • Percentage Held by Institutions

    Surgery Partners has minimal institutional ownership at this time.

  • Read more about Surgery Partners' insider trading history.
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SGRY Stock News Headlines

Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
Surgery Partners: Q2 Earnings Snapshot
See More Headlines

SGRY Stock Analysis - Frequently Asked Questions

Surgery Partners' stock was trading at $15.45 at the beginning of 2026. Since then, SGRY shares have decreased by 8.3% and is now trading at $14.17.

Surgery Partners, Inc. (NASDAQ:SGRY) released its earnings results on Monday, August, 10th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.04. The firm's revenue was up 2.7% on a year-over-year basis.
Read the conference call transcript
.

Surgery Partners' board approved a stock buyback program on Thursday, February 26th 2026, which allows the company to buy back $200,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 9.7% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board believes its stock is undervalued.

Surgery Partners (SGRY) raised $350 million in an IPO on Thursday, October 1st 2015. The company issued 14,285,000 shares at $23.00-$26.00 per share.

Top institutional shareholders of Surgery Partners include Jupiter Topco LLC (10.60%), Pentwater Capital Management LP (8.88%), BlackRock Inc. (4.77%) and Hsbc Holdings PLC (2.26%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, Jennifer Baldock, David T Doherty, Wayne S Deveydt, Harrison R Bane, Marissa Brittenham, Danielle Burkhalter, William Trenton Webb, Bradley R Owens and Teresa Deluca.
View institutional ownership trends
.

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE).

Company Calendar

Last Earnings
8/10/2026
Today
9/03/2026
Next Earnings (Estimated)
11/09/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Facilities
Current Symbol
NASDAQ:SGRY
CIK
1638833
Employees
16,000
Year Founded
2004

Price Target and Rating

High Price Target
$30.00
Low Price Target
$14.00
Potential Upside/Downside
+37.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.55
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
64.41
P/E Growth
4.31
Net Income
-$77.90 million
Net Margins
-2.63%
Pretax Margin
3.04%
Return on Equity
0.88%
Return on Assets
0.34%

Debt

Debt-to-Equity Ratio
1.18
Current Ratio
1.95
Quick Ratio
1.78

Sales & Book Value

Annual Sales
$3.31 billion
Price / Sales
0.56
Cash Flow
$1.73 per share
Price / Cash Flow
8.19
Book Value
$23.69 per share
Price / Book
0.60

Miscellaneous

Outstanding Shares
130,920,000
Free Float
128,300,000
Market Cap
$1.86 billion
Optionable
Optionable
Beta
1.92

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:SGRY) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners